591 related articles for article (PubMed ID: 31907178)
1. Hydroxylamine and Carboxymethoxylamine Can Inhibit
Li J; Guo H; Galon EM; Gao Y; Lee SH; Liu M; Li Y; Ji S; Jia H; Xuan X
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31907178
[No Abstract] [Full Text] [Related]
2. Characterization of strain-specific phenotypes associated with knockout of dense granule protein 9 in Toxoplasma gondii.
Guo H; Gao Y; Jia H; Moumouni PFA; Masatani T; Liu M; Lee SH; Galon EM; Li J; Li Y; Tumwebaze MA; Benedicto B; Xuan X
Mol Biochem Parasitol; 2019 Apr; 229():53-61. PubMed ID: 30849416
[TBL] [Abstract][Full Text] [Related]
3. Two old drugs, NVP-AEW541 and GSK-J4, repurposed against the Toxoplasma gondii RH strain.
Liu S; Wu M; Hua Q; Lu D; Tian Y; Yu H; Cheng L; Chen Y; Cao J; Hu X; Tan F
Parasit Vectors; 2020 May; 13(1):242. PubMed ID: 32393321
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Plasmodium Atg3-Atg8 Interaction Inhibitors Identifies Novel Alternative Mechanisms of Action in Toxoplasma gondii.
Varberg JM; LaFavers KA; Arrizabalaga G; Sullivan WJ
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158278
[TBL] [Abstract][Full Text] [Related]
5. Determination of stage interconversion in vitro and in vivo by construction of transgenic Toxoplasma gondii that stably express stage-specific fluorescent proteins.
Zhang H; Zhang Y; Cao J; Zhou Y; Wang N; Zhou J
Exp Parasitol; 2013 Jul; 134(3):275-80. PubMed ID: 23545429
[TBL] [Abstract][Full Text] [Related]
6. Sterculic Acid and Its Analogues Are Potent Inhibitors of Toxoplasma gondii.
Hao P; Alaraj IQ; Dulayymi JR; Baird MS; Liu J; Liu Q
Korean J Parasitol; 2016 Apr; 54(2):139-45. PubMed ID: 27180571
[TBL] [Abstract][Full Text] [Related]
7. Pravastatin and Simvastatin Pretreatment in Combination with Pyrimethamine and Sulfadiazine Reduces Infection Process of Toxoplasma gondii Tachyzoites (RH Strain) in HeLa Cells.
Sanfelice RADS; da Silva SS; Bosqui LR; Machado LF; Miranda-Sapla MM; Panagio LA; Navarro IT; Conchon-Costa I; Pavanelli WR; Almeida RS; Costa IN
Acta Parasitol; 2019 Sep; 64(3):612-616. PubMed ID: 31286354
[TBL] [Abstract][Full Text] [Related]
8. Role of
Kannan G; Di Cristina M; Schultz AJ; Huynh MH; Wang F; Schultz TL; Lunghi M; Coppens I; Carruthers VB
mBio; 2019 Aug; 10(4):. PubMed ID: 31387907
[No Abstract] [Full Text] [Related]
9. Screening of a library of traditional Chinese medicines to identify compounds and extracts which inhibit Toxoplasma gondii growth.
Saito H; Murata Y; Nonaka M; Kato K
J Vet Med Sci; 2020 Feb; 82(2):184-187. PubMed ID: 31904004
[TBL] [Abstract][Full Text] [Related]
10. Functional Characterization of Dense Granule Proteins in
Bai MJ; Wang JL; Elsheikha HM; Liang QL; Chen K; Nie LB; Zhu XQ
Front Cell Infect Microbiol; 2018; 8():300. PubMed ID: 30211128
[TBL] [Abstract][Full Text] [Related]
11. TgTKL1 Is a Unique Plant-Like Nuclear Kinase That Plays an Essential Role in Acute Toxoplasmosis.
Varberg JM; Coppens I; Arrizabalaga G; Gaji RY
mBio; 2018 Mar; 9(2):. PubMed ID: 29559568
[TBL] [Abstract][Full Text] [Related]
12. Metabolic Cooperation of Glucose and Glutamine Is Essential for the Lytic Cycle of Obligate Intracellular Parasite Toxoplasma gondii.
Nitzsche R; Zagoriy V; Lucius R; Gupta N
J Biol Chem; 2016 Jan; 291(1):126-41. PubMed ID: 26518878
[TBL] [Abstract][Full Text] [Related]
13. Targeted Structure-Activity Analysis of Endochin-like Quinolones Reveals Potent Qi and Qo Site Inhibitors of Toxoplasma gondii and Plasmodium falciparum Cytochrome bc
McConnell EV; Bruzual I; Pou S; Winter R; Dodean RA; Smilkstein MJ; Krollenbrock A; Nilsen A; Zakharov LN; Riscoe MK; Doggett JS
ACS Infect Dis; 2018 Nov; 4(11):1574-1584. PubMed ID: 30117728
[TBL] [Abstract][Full Text] [Related]
14. Auranofin is highly efficacious against Toxoplasma gondii in vitro and in an in vivo experimental model of acute toxoplasmosis.
Andrade RM; Chaparro JD; Capparelli E; Reed SL
PLoS Negl Trop Dis; 2014; 8(7):e2973. PubMed ID: 25079790
[TBL] [Abstract][Full Text] [Related]
15. Rapid discovery of inhibitors of Toxoplasma gondii using hybrid structure-based computational approach.
Kortagere S; Mui E; McLeod R; Welsh WJ
J Comput Aided Mol Des; 2011 May; 25(5):403-11. PubMed ID: 21359560
[TBL] [Abstract][Full Text] [Related]
16. Effects of dextran sulfates on the acute infection and growth stages of Toxoplasma gondii.
Ishiwa A; Kobayashi K; Takemae H; Sugi T; Gong H; Recuenco FC; Murakoshi F; Inomata A; Horimoto T; Kato K
Parasitol Res; 2013 Dec; 112(12):4169-76. PubMed ID: 24096605
[TBL] [Abstract][Full Text] [Related]
17. Development of an in vitro system to study the developmental stages of Toxoplasma gondii using a genetically modified strain expressing markers for tachyzoites and bradyzoites.
Portes JA; De Souza W
Parasitol Res; 2019 Dec; 118(12):3479-3489. PubMed ID: 31728720
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a Toxoplasma gondii calcium calmodulin-dependent protein kinase homolog.
Kato K; Sugi T; Takemae H; Takano R; Gong H; Ishiwa A; Horimoto T; Akashi H
Parasit Vectors; 2016 Jul; 9(1):405. PubMed ID: 27444499
[TBL] [Abstract][Full Text] [Related]
19. Effects of PERK eIF2α Kinase Inhibitor against Toxoplasma gondii.
Augusto L; Martynowicz J; Staschke KA; Wek RC; Sullivan WJ
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30181373
[No Abstract] [Full Text] [Related]
20. In Vitro and In Vivo Effects of the Bumped Kinase Inhibitor 1294 in the Related Cyst-Forming Apicomplexans Toxoplasma gondii and Neospora caninum.
Winzer P; Müller J; Aguado-Martínez A; Rahman M; Balmer V; Manser V; Ortega-Mora LM; Ojo KK; Fan E; Maly DJ; Van Voorhis WC; Hemphill A
Antimicrob Agents Chemother; 2015 Oct; 59(10):6361-74. PubMed ID: 26248379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
